Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging
NCT: NCT07620288 · NOT_YET_RECRUITING
Brief Summary
The proposed project will investigate the neurobiological mechanisms of accelerated intermittent Theta Burst Stimulation (iTBS) in major depressive disorder (MDD) using an advanced multimodal imaging approach. This single-arm, within-subject study will deliver one week of accelerated iTBS and use pre-/post-treatment PET/MRI to quantify changes in synaptic density, functional connectivity, and microstructural integrity. We will combine \[¹⁸F\]SynVesT-1 PET with functional, neurochemical and anatomical MRI, such as resting-state fMRI, magnetic resonance spectroscopy (MRS) and neurite orientation dispersion and density imaging (NODDI), to capture treatment-related plasticity. This integrated design will link molecular and network-level mechanisms to clinical improvement, providing an unprecedented mechanistic map of how accelerated iTBS restores brain function in depression.
Frequently Asked Questions
What is Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging?
Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging is a clinical trial registered under NCT07620288. Current status: NOT_YET_RECRUITING.
What is the status of NCT07620288?
The current status of NCT07620288 (Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging) is: NOT_YET_RECRUITING.
When did Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging start?
Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging started on 2026-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.